Standard Article

Antifungal Agents and Antifungal Susceptibility Testing

Medical Mycology

Therapeutic Agents and Vaccines

  1. Sanjay G. Revankar MD Associate Professor of Medicine1,2,
  2. John R. Graybill Professor of Medicine3,
  3. Thomas F. Patterson MD FACP Professor of Medicine, Director4

Published Online: 15 MAR 2010

DOI: 10.1002/9780470688618.taw0134

Topley and Wilson's Microbiology and Microbial Infections

Topley and Wilson's Microbiology and Microbial Infections

How to Cite

Revankar, S. G., Graybill, J. R. and Patterson, T. F. 2010. Antifungal Agents and Antifungal Susceptibility Testing. Topley and Wilson's Microbiology and Microbial Infections. .

Author Information

  1. 1

    Dallas VA Medical Center, Division of Infectious Diseases

  2. 2

    UT Southwestern, Department of Medicine, Dallas, TX, USA

  3. 3

    University of Texas, Division of Infectious Diseases, Health Science Center, San Antonio, TX, USA

  4. 4

    The University of Texas Health Science Center at San Antonio, San Antonio Center for Medical Mycology, San Antonio, TX, USA

Publication History

  1. Published Online: 15 MAR 2010

Abstract

  • 1
    Systemic Antifungal Drugs in Current Use
  • 2
    Future Antifungal Drugs
  • 3
    Antifungal Susceptibility Testing
  • 4
    Methods of Susceptibility Testing

Keywords:

  • antifungal agents and antifungal susceptibility testing;
  • systemic antifungal drugs in current use;
  • antifungal mechanisms of action;
  • lipid vehicles for polyenes;
  • unique mechanism of action-setting echinocandins apart from other antifungals;
  • antifungal susceptibility testing;
  • future antifungal drugs;
  • testing of filamentous fungi